Status:
COMPLETED
Evaluation of Quality Indicators on Analgesia, Sedation and Delirium in Intensive Care Patients and Their Impact on Outcome Indicators and Economic Indicators
Lead Sponsor:
Charite University, Berlin, Germany
Conditions:
Delirium
Pain
Eligibility:
All Genders
18+ years
Brief Summary
Retrospective cohort study to investigate the adherence to the process indicators for pain management, sedation management and management of delirium on outcome indicators and cost/revenues in individ...
Detailed Description
The evaluation of quality-related process indicators (in this case, Quality Indicator II of the Intensive Care Quality Indicators of the DIVI\*: Management of Analgesia, Sedation and Delirium) will be...
Eligibility Criteria
Inclusion
- Age ≥ 18 years
Exclusion
- Incomplete electronic records
Key Trial Info
Start Date :
May 12 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 1 2024
Estimated Enrollment :
20220 Patients enrolled
Trial Details
Trial ID
NCT05384613
Start Date
May 12 2022
End Date
August 1 2024
Last Update
February 14 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Charité - University Medicine Berlin
Berlin, Germany, 13353